Teva Pharmaceuticals has announced it will acquire Gecko Health Innovations, a smart inhaler company.
Gecko’s main product is CareTRx a platform for chronic respiratory disease management that combines a sensor device that connects to most inhalers, a data analytics platform, an accessible user interface, and behavioral triggers to help asthma and COPD patients manage their condition.
Gecko Health Innovations founders Mark Maalouf and Dr. Yechiel Engelhard will work with Teva to explore ways to apply the CareTRx technology to Teva’s product pipeline and portfolio of respiratory products with the goal of improving clinical outcomes.
Gecko was one of the early entries to the rapidly crowding smart inhaler space. The company began in 2012 as the winning team in an MIT Media Lab Health and Wellness Innovation event. The product that grew out of that event, called Gecko Cap, was aimed at kids and used gamification and rewards to help motivate them to use their inhaler.